N. Varol
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 9
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Sarah Goring (7 shared papers)Phil McEwan (2 shared papers)Kristina S. Boye (3 shared papers)Ellen Korol (1 shared paper)James L. Palmer (2 shared papers)V. Foos (4 shared papers)David Grant (4 shared papers)Frank Griesinger (1 shared paper)
- Journals
- Value in Health (9 papers)Lung Cancer (3 papers)Journal of Medical Economics (3 papers)Annals of Oncology (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
N. Varol
23 papers receiving 299 citations
Peers
Comparison fields: 5 of 55
- Endocrinology, Diabetes and Metabolism 114
- Oncology 63
- Pulmonary and Respiratory Medicine 43
- Cancer Research 13
- Toxicology 3
Countries citing papers authored by N. Varol
This map shows the geographic impact of N. Varol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Varol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Varol more than expected).
Fields of papers citing papers by N. Varol
This network shows the impact of papers produced by N. Varol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Varol. The network helps show where N. Varol may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Varol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 99 | |
| 2 | 2019 | 91 | |
| 3 | 2014 | 41 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 7 | |
| 7 | 2018 | 6 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 5 | |
| 11 | 2013 | 3 | |
| 12 | 2014 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2013 | 1 | |
| 15 | 2018 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2021 | 1 |
About N. Varol
N. Varol is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Surgery, having authored 26 papers that have together received 305 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Diabetes Treatment and Management (5 papers), Lung Cancer Treatments and Mutations (5 papers), Diabetes Management and Research (4 papers), Economic and Financial Impacts of Cancer (4 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (114 citations), Oncology (63 citations), Pulmonary and Respiratory Medicine (43 citations), Cancer Research (13 citations) and Toxicology (3 citations). N. Varol has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Sarah Goring, Phil McEwan, Kristina S. Boye, Ellen Korol, James L. Palmer, V. Foos, David Grant, Frank Griesinger, Sheena Kayaniyil and Bradley Curtis. Their work appears in journals such as Value in Health, Lung Cancer, Journal of Medical Economics, Annals of Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.